The Drugs for Vulvovaginal Candidiasis Market is expanding as healthcare awareness among women continues to improve. Increasing fungal infection rates, better diagnostic capabilities, and wider availability of antifungal medications are supporting market development worldwide. According to The Insight Partners, the Drugs for Vulvovaginal Candidiasis Market was valued at US$ 852.46 million in...